The strong beat and guidance raise, combined with positive adjusted EBITDA and accelerating physician adoption, suggest SIBN is gaining operating leverage. Watch for continued margin expansion and the upcoming iFuse Bedrock Granite MS-DRG catalyst from CMS. The stock may re-rate higher if revenue growth sustains above 14%.
Price Chart
Executive Summary
SI-BONE reported Q1 2026 revenue of $52.6M (+11.2% YoY) and a net loss of $0.10 per share, beating consensus EPS of -$0.19 by 79.1%. The company raised its full-year 2026 revenue guidance to $230M-$233M and gross margin guidance to ~79%, reflecting accelerating commercial momentum and new product launches.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $52.6M, +11.2% YoY vs $47.3M
- EPS -$0.10 vs consensus -$0.19 (79.1% beat)
- Gross margin stable at 79.8%
- Operating loss improved 31.9% to -$5.1M
- Adjusted EBITDA turned positive at $2.5M vs $0.5M YoY
- Raised FY2026 revenue guidance to $230M-$233M (prior $228.5M-$232.5M)
- Raised FY2026 gross margin guidance to ~79% (prior ~78%)
- Cash and equivalents $144.7M, down slightly from $147.8M
- Active U.S. physicians grew 17% to over 1,650
- International revenue +33.9% to $3.3M
Financial Impact
Revenue beat of ~$1.4M vs consensus; EPS beat of $0.15 vs consensus; guidance raise implies ~$1M-$1.5M incremental revenue at midpoint
Risk Factors
- Still GAAP unprofitable with accumulated deficit of $454.6M
- Operating cash flow negative at -$2.4M in Q1
- Dependence on CMS reimbursement for new MS-DRG proposal
- Tariff and supply chain risks noted in forward-looking statements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3292346 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | Press Release | $20.54 | awaiting T+20 | — | $21.48 (+4.58%) |
Oct 13, 2026 13d ago | 144 | $19.68 | awaiting T+20 | — | $21.48 (+9.15%) |
Aug 26, 2026 8w ago | Insider Cluster | $19.20 $18.52 | ▲ +3.54% | ▲ +3.03% | $21.48 (−11.87%) |
Aug 21, 2026 9w ago | Insider Cluster | $19.47 $18.81 | ▲ +3.39% | ▲ +4.70% | $21.48 (−10.32%) |
Aug 21, 2026 9w ago | 144 | $19.47 $18.81 | ▼ −3.39% | ▼ −4.70% | $21.48 (+10.32%) |
Aug 18, 2026 9w ago | Insider Cluster | $19.91 $18.04 | ▼ −9.39% | ▼ −7.44% | $21.48 (+7.89%) |
Aug 18, 2026 9w ago | Insider Cluster | $19.91 $18.04 | ▼ −9.39% | ▼ −7.44% | $21.48 (+7.89%) |
Aug 3, 2026 12w ago | Press Release | $18.44 $18.92 | ▲ +2.60% | ▲ +3.84% | $21.48 (+16.49%) |
Jun 8, 2026 20w ago | Insider Cluster | $15.53 $17.30 | ▲ +11.40% | ▲ +9.95% | $21.48 (+38.31%) |
Jun 8, 2026 20w ago | 8-K | $15.53 $17.30 | ▲ +11.40% | ▲ +9.95% | $21.48 (+38.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers